YieldMax MRNA Option Income Strategy ETF
$18.323.21 %$MRNY
About YieldMax MRNA Option Income Strategy ETF (MRNY)
YieldMax MRNA Option Income Strategy ETF (MRNY) is an exchange-traded fund established on October 23, 2023 and traded on the NYSE exchange. The fund manages approximately $0.09 billion in net assets, making it a significant ETF in its category.
With an expense ratio of 1.27%, YieldMax MRNA Option Income Strategy ETF is considered a competitive investment option for investors seeking exposure to this asset class.
The fund currently offers a dividend yield of 1.50%, providing income-seeking investors with supplemental distributions alongside potential capital appreciation.
What You Need to Know About MRNY
- Inception Date: October 23, 2023 - providing 2 years of track record
- Assets Under Management: $0.09 billion in net assets
- Expense Ratio: 1.27% annually
- Dividend Yield: 1.50% annual yield
- Exchange: NYSE
- Type: Traditional ETF
Compare MRNY with other investment options: ETF Screener | Stock Screener
Price History
▲+5.46%
Fund Details
Dividend Yield1.50%
Inception Date2023-10-23
Net Assets$90.4M
Net Expense Ratio0.01%